Principal Investigator
Jaime Merchan
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220363
Clinical Trial Summary
A Phase 1/Phase 2 Study to Evaluate the Safety and Tolerability of MK-1088 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (407) 7659589